Selling to Employers

Will Amazon ruin voice biomarkers? Amwell S-1 insights.

8.28.20

8 min. Read

Nine thoughts on Teladongo. CPT sneak peek.

8.07.20

8 min. Read

Hinge plans virtual MSK clinic. Livongo upping focus on DPP?

7.31.20

5 min. Read

Livongo’s IPO anniversary. DTx pipelines.

7.24.20

7 min. Read

Haven’s health coach partner went public. French reimbursement.

6.12.20

6 min. Read

M&A: Omada-Physera. Optum-AbleTo. Elekta-Kaiku.

5.22.20

6 min. Read

Why Omada Health should buy Physera and other MSK M&A digital health predictions

5.16.20

5 min. Read

Livongo: 10 percent utilization uptick. $215M RWE acquisition.

4.10.20

6 min. Read

RCT shows no effect for AI coach. Livongo ups enrollment rate.

3.06.20

8 min. Read

Strip companies tried to kill Livongo. Sanofi DTx distro.

2.28.20

8 min. Read